Steven Leckie

University of Pittsburgh Medical Center

Papers

1

Total Citations

61

H-Index

1

About

Steven Leckie is a leading orthopedic surgeon and researcher whose work focuses on the regenerative treatment of intervertebral disc degeneration. His most influential contribution stems from a landmark 2013 study demonstrating that injecting human umbilical tissue-derived cells into the nucleus pulposus can alter the course of disc degeneration in vivo. This paper, cited 61 times, has opened new avenues for cell-based therapies in spinal disorders, challenging the traditional view that disc degeneration is irreversible. Leckie’s research bridges the gap between basic science and clinical application, offering hope for non-surgical interventions that could restore disc function and alleviate chronic back pain. His work is particularly notable for its translational impact, as it provides a foundation for future clinical trials in regenerative orthopedics. By targeting the cellular mechanisms of disc aging, Leckie has positioned himself at the forefront of a paradigm shift in spine care, moving from palliative management toward true biological repair. His findings continue to inspire researchers exploring stem cell therapies for musculoskeletal degeneration.

Research Focus

Key Achievements

1
H-Index
1
Papers
61
Total Citations
61
Avg Citations/Paper
🏆 Most Cited Paper
Injection of human umbilical tissue–derived cells into the nucleus pulposus alters the course of intervertebral disc degeneration in vivo
61 citations · 2013
📈 Most Prolific Year: 2013 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: University of Pittsburgh Medical Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago